Solventum Corporation (SOLV) 10-Year Financial Performance & Capital Metrics

SOLV •

HealthcareHealthcare FacilitiesHealthcare staffing and facility services

AboutSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Show more

Revenue $8.32B +0.9%
EBITDA $2.18B +37.1%
Net Income $1.56B +224.8%
EPS (Diluted) 8.88 +221.7%
Gross Margin 53.47% -3.9%
EBITDA Margin 26.2% +35.9%
Operating Margin 26.2% +108.7%
Net Margin 18.69% +222.1%
ROE 38.86% +493.3%
ROIC 16.85% +225.1%
Debt/Equity 1.00 -63.2%
Interest Coverage 6.29 +122.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Good 3Y average ROE of 19.0%
✓Healthy 5Y average net margin of 15.1%

✗Weaknesses

✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y0.79%

TTM0.86%

Profit (Net Income) CAGR

10Y-

5Y-

3Y5.03%

TTM224.84%

EPS CAGR

10Y-

5Y-

3Y4.46%

TTM221.74%

ROCE

10Y Avg13.98%

5Y Avg13.98%

3Y Avg13.83%

Latest19.04%

Peer Comparison

Healthcare staffing and facility services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CCELCryo-Cell International, Inc.	27.15M	3.37	67.40	2.05%	1.26%		13.29%
HCSGHealthcare Services Group, Inc.	1.67B	21.77	26.88	7.08%	2.2%	8.01%	8.32%	0.03
SOLVSolventum Corporation	12.87B	74.20	8.36	0.86%	18.69%	30.82%		1.00
AMSAmerican Shared Hospital Services	13.74M	2.11	6.39	32.9%	-7.65%	-7.87%		0.77
SYRASyra Health Corp. Class A Common Stock	60K	0.10	-0.19	44.73%	-16.89%	-57.31%		0.16
AMNAMN Healthcare Services, Inc.	987.48M	19.48	-5.06	-21.26%	-3.5%	-14.9%	24.26%	1.55
CCRNCross Country Healthcare, Inc.	280.81M	8.70	-19.77	-33.46%	-1.39%	-3.84%	39.67%	0.01

Profit & Loss

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	8.17B	8.13B	8.2B	8.25B	8.32B
Revenue Growth %	-	-0.5%	0.82%	0.7%	0.86%
Cost of Goods Sold+	3.25B	3.44B	3.5B	3.66B	3.87B
COGS % of Revenue	39.75%	42.25%	42.75%	44.35%	46.53%
Gross Profit+	4.92B	4.7B	4.69B	4.59B	4.45B
Gross Margin %	60.25%	57.75%	57.25%	55.65%	53.47%
Gross Profit Growth %	-	-4.63%	-0.04%	-2.13%	-3.09%
Operating Expenses+	3.04B	3B	3B	3.56B	3.82B
OpEx % of Revenue	37.25%	36.93%	36.61%	43.09%	45.87%
Selling, General & Admin	2.28B	2.23B	2.24B	2.78B	3.08B
SG&A % of Revenue	27.88%	27.49%	27.36%	33.7%	37%
Research & Development	766M	767M	758M	775M	739M
R&D % of Revenue	9.37%	9.43%	9.25%	9.39%	8.88%
Other Operating Expenses	0	0	0	0	0
Operating Income+	1.88B	1.69B	1.69B	1.04B	2.18B
Operating Margin %	23%	20.82%	20.64%	12.55%	26.2%
Operating Income Growth %	-	-9.9%	-0.06%	-38.77%	110.52%
EBITDA+	2.48B	2.27B	2.25B	1.59B	2.18B
EBITDA Margin %	30.3%	27.93%	27.49%	19.28%	26.2%
EBITDA Growth %	-	-8.28%	-0.79%	-29.38%	37.08%
D&A (Non-Cash Add-back)	597M	578M	561M	555M	0
EBIT	1.88B	1.69B	1.67B	972M	0
Net Interest Income+	0	0	0	-367M	0
Interest Income	0	0	0	0	0
Interest Expense	0	0	0	367M	347M
Other Income/Expense	3M	-1M	-25M	-431M	-468M
Pretax Income+	1.88B	1.69B	1.67B	605M	1.71B
Pretax Margin %	23.03%	20.81%	20.34%	7.33%	20.58%
Income Tax+	422M	349M	321M	127M	157M
Effective Tax Rate %	77.58%	79.37%	80.74%	79.17%	90.83%
Net Income+	1.46B	1.34B	1.35B	479M	1.56B
Net Margin %	17.87%	16.52%	16.42%	5.8%	18.69%
Net Income Growth %	-	-8.01%	0.22%	-64.41%	224.84%
Net Income (Continuing)	1.46B	1.34B	1.35B	478M	1.56B
Discontinued Operations	0	0	0	0	0
Minority Interest	0	0	0	0	0
EPS (Diluted)+	8.47	7.79	7.79	2.76	8.88
EPS Growth %	-	-8.03%	0.04%	-64.59%	221.74%
EPS (Basic)	8.47	7.79	7.79	2.77	8.94
Diluted Shares Outstanding	172.47M	172.47M	172.71M	173.7M	175.3M
Basic Shares Outstanding	172.47M	172.47M	172.71M	173.2M	174.1M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	2.19B	2.23B	2.52B	3.25B	3.86B
Cash & Short-Term Investments	91M	61M	194M	762M	878M
Cash Only	91M	61M	194M	762M	878M
Short-Term Investments	0	0	0	0	0
Accounts Receivable	1.18B	1.17B	1.31B	1.23B	1.03B
Days Sales Outstanding	52.58	52.57	58.47	54.35	45.33
Inventory	813M	873M	857M	965M	1.07B
Days Inventory Outstanding	91.36	92.76	89.27	96.21	100.44
Other Current Assets	108M	126M	155M	293M	881M
Total Non-Current Assets+	11.89B	11.36B	11.42B	11.21B	10.44B
Property, Plant & Equipment	1.31B	1.32B	1.46B	1.62B	1.33B
Fixed Asset Turnover	6.26x	6.16x	5.63x	5.09x	6.28x
Goodwill	6.67B	6.43B	6.54B	6.38B	5.7B
Intangible Assets	3.66B	3.25B	2.9B	2.54B	2.59B
Long-Term Investments	0	0	0	0	0
Other Non-Current Assets	253M	358M	530M	665M	813M
Total Assets+	14.07B	13.59B	13.94B	14.46B	14.29B
Asset Turnover	0.58x	0.60x	0.59x	0.57x	0.58x
Asset Growth %	-	-3.42%	2.57%	3.69%	-1.13%
Total Current Liabilities+	1.41B	1.31B	1.73B	2.7B	3.14B
Accounts Payable	320M	348M	477M	618M	687M
Days Payables Outstanding	35.96	36.98	49.69	61.61	64.73
Short-Term Debt	0	0	0	200M	0
Deferred Revenue (Current)	574M	559M	574M	572M	621M
Other Current Liabilities	323M	236M	365M	659M	2.52B
Current Ratio	1.56x	1.70x	1.46x	1.20x	1.23x
Quick Ratio	0.98x	1.04x	0.96x	0.84x	0.89x
Cash Conversion Cycle	107.98	108.36	98.05	88.94	81.04
Total Non-Current Liabilities+	610M	541M	549M	8.79B	6.11B
Long-Term Debt	0	0	8.3B	7.81B	5.04B
Capital Lease Obligations	0	0	0	0	0
Deferred Tax Liabilities	218M	215M	231M	225M	164M
Other Non-Current Liabilities	392M	326M	-7.99B	760M	910M
Total Liabilities	2.02B	1.85B	2.28B	11.5B	9.24B
Total Debt+	0	0	8.3B	8.01B	5.04B
Net Debt	-91M	-61M	8.11B	7.25B	4.16B
Debt / Equity	-	-	0.71x	2.71x	1.00x
Debt / EBITDA	-	-	3.69x	5.03x	2.31x
Net Debt / EBITDA	-0.04x	-0.03x	3.60x	4.56x	1.91x
Interest Coverage	-	-	-	2.82x	6.29x
Total Equity+	12.06B	11.74B	11.67B	2.96B	5.05B
Equity Growth %	-	-2.63%	-0.65%	-74.64%	70.63%
Book Value per Share	69.92	68.08	67.55	17.04	28.80
Total Shareholders' Equity	12.06B	11.74B	11.67B	2.96B	5.05B
Common Stock	0	0	0	2M	2M
Retained Earnings	0	0	0	242M	1.8B
Treasury Stock	0	0	0	0	0
Accumulated OCI	-200M	-497M	-337M	-1.06B	-625M
Minority Interest	0	0	0	0	0

Cash Flow

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	2.2B	1.68B	1.92B	1.19B	369M
Operating CF Margin %	26.95%	20.65%	23.36%	14.36%	4.43%
Operating CF Growth %	-	-23.75%	14.06%	-38.12%	-68.86%
Net Income	1.46B	1.34B	1.35B	479M	1.56B
Depreciation & Amortization	597M	578M	561M	555M	489M
Stock-Based Compensation	38M	37M	39M	112M	161M
Deferred Taxes	-34M	-141M	-142M	-155M	-120M
Other Non-Cash Items	74M	64M	-15M	34M	-1.72B
Working Capital Changes	67M	-202M	126M	160M	0
Change in Receivables	-1M	-32M	-129M	276M	34M
Change in Inventory	-136M	-82M	23M	-132M	-139M
Change in Payables	68M	25M	105M	266M	104M
Cash from Investing+	-278M	-253M	-230M	-380M	2.8B
Capital Expenditures	-277M	-251M	-290M	-380M	-379M
CapEx % of Revenue	3.39%	3.09%	3.54%	4.6%	4.55%
Acquisitions	0	0	60M	0	-696M
Investments	-	-	-	-	-
Other Investing	-1M	-2M	0	0	3.87B
Cash from Financing+	-1.96B	-1.46B	-1.55B	-240M	-3.06B
Debt Issued (Net)	0	0	0	8B	0
Equity Issued (Net)	0	0	0	0	0
Dividends Paid	0	0	0	0	0
Share Repurchases	0	0	0	0	0
Other Financing	-1.96B	-1.46B	-1.55B	-8.24B	-3.06B
Net Change in Cash	-33M	-30M	133M	568M	116M
Free Cash Flow+	1.93B	1.43B	1.63B	805M	-10M
FCF Margin %	23.56%	17.56%	19.82%	9.75%	-0.12%
FCF Growth %	-	-25.82%	13.8%	-50.46%	-101.24%
FCF per Share	11.16	8.28	9.41	4.63	-0.06
FCF Conversion (FCF/Net Income)	1.51x	1.25x	1.42x	2.47x	0.24x
Interest Paid	0	0	0	287M	0
Taxes Paid	0	0	0	244M	0

Key Ratios

Metric	2021	2022	2023	2024	2025
Return on Equity (ROE)	12.11%	11.29%	11.5%	6.55%	38.86%
Return on Invested Capital (ROIC)	11.78%	10.74%	8.07%	5.18%	16.85%
Gross Margin	60.25%	57.75%	57.25%	55.65%	53.47%
Net Margin	17.87%	16.52%	16.42%	5.8%	18.69%
Debt / Equity	-	-	0.71x	2.71x	1.00x
Interest Coverage	-	-	-	2.82x	6.29x
FCF Conversion	1.51x	1.25x	1.42x	2.47x	0.24x
Revenue Growth	-	-0.5%	0.82%	0.7%	0.86%

← Back to Screener

US Stock Screener

...

Solventum Corporation (SOLV) 10-Year Financial Performance & Capital Metrics

SOLV •

HealthcareHealthcare FacilitiesHealthcare staffing and facility services

Revenue $8.32B +0.9%
EBITDA $2.18B +37.1%
Net Income $1.56B +224.8%
EPS (Diluted) 8.88 +221.7%
Gross Margin 53.47% -3.9%
EBITDA Margin 26.2% +35.9%
Operating Margin 26.2% +108.7%
Net Margin 18.69% +222.1%
ROE 38.86% +493.3%
ROIC 16.85% +225.1%
Debt/Equity 1.00 -63.2%
Interest Coverage 6.29 +122.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Good 3Y average ROE of 19.0%
✓Healthy 5Y average net margin of 15.1%

✗Weaknesses

✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y0.79%

TTM0.86%

Profit (Net Income) CAGR

10Y-

5Y-

3Y5.03%

TTM224.84%

EPS CAGR

10Y-

5Y-

3Y4.46%

TTM221.74%

ROCE

10Y Avg13.98%

5Y Avg13.98%

3Y Avg13.83%

Latest19.04%

Peer Comparison

Healthcare staffing and facility services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CCELCryo-Cell International, Inc.	27.15M	3.37	67.40	2.05%	1.26%		13.29%
HCSGHealthcare Services Group, Inc.	1.67B	21.77	26.88	7.08%	2.2%	8.01%	8.32%	0.03
SOLVSolventum Corporation	12.87B	74.20	8.36	0.86%	18.69%	30.82%		1.00
AMSAmerican Shared Hospital Services	13.74M	2.11	6.39	32.9%	-7.65%	-7.87%		0.77
SYRASyra Health Corp. Class A Common Stock	60K	0.10	-0.19	44.73%	-16.89%	-57.31%		0.16
AMNAMN Healthcare Services, Inc.	987.48M	19.48	-5.06	-21.26%	-3.5%	-14.9%	24.26%	1.55
CCRNCross Country Healthcare, Inc.	280.81M	8.70	-19.77	-33.46%	-1.39%	-3.84%	39.67%	0.01

Profit & Loss

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	8.17B	8.13B	8.2B	8.25B	8.32B
Revenue Growth %	-	-0.5%	0.82%	0.7%	0.86%
Cost of Goods Sold+	3.25B	3.44B	3.5B	3.66B	3.87B
COGS % of Revenue	39.75%	42.25%	42.75%	44.35%	46.53%
Gross Profit+	4.92B	4.7B	4.69B	4.59B	4.45B
Gross Margin %	60.25%	57.75%	57.25%	55.65%	53.47%
Gross Profit Growth %	-	-4.63%	-0.04%	-2.13%	-3.09%
Operating Expenses+	3.04B	3B	3B	3.56B	3.82B
OpEx % of Revenue	37.25%	36.93%	36.61%	43.09%	45.87%
Selling, General & Admin	2.28B	2.23B	2.24B	2.78B	3.08B
SG&A % of Revenue	27.88%	27.49%	27.36%	33.7%	37%
Research & Development	766M	767M	758M	775M	739M
R&D % of Revenue	9.37%	9.43%	9.25%	9.39%	8.88%
Other Operating Expenses	0	0	0	0	0
Operating Income+	1.88B	1.69B	1.69B	1.04B	2.18B
Operating Margin %	23%	20.82%	20.64%	12.55%	26.2%
Operating Income Growth %	-	-9.9%	-0.06%	-38.77%	110.52%
EBITDA+	2.48B	2.27B	2.25B	1.59B	2.18B
EBITDA Margin %	30.3%	27.93%	27.49%	19.28%	26.2%
EBITDA Growth %	-	-8.28%	-0.79%	-29.38%	37.08%
D&A (Non-Cash Add-back)	597M	578M	561M	555M	0
EBIT	1.88B	1.69B	1.67B	972M	0
Net Interest Income+	0	0	0	-367M	0
Interest Income	0	0	0	0	0
Interest Expense	0	0	0	367M	347M
Other Income/Expense	3M	-1M	-25M	-431M	-468M
Pretax Income+	1.88B	1.69B	1.67B	605M	1.71B
Pretax Margin %	23.03%	20.81%	20.34%	7.33%	20.58%
Income Tax+	422M	349M	321M	127M	157M
Effective Tax Rate %	77.58%	79.37%	80.74%	79.17%	90.83%
Net Income+	1.46B	1.34B	1.35B	479M	1.56B
Net Margin %	17.87%	16.52%	16.42%	5.8%	18.69%
Net Income Growth %	-	-8.01%	0.22%	-64.41%	224.84%
Net Income (Continuing)	1.46B	1.34B	1.35B	478M	1.56B
Discontinued Operations	0	0	0	0	0
Minority Interest	0	0	0	0	0
EPS (Diluted)+	8.47	7.79	7.79	2.76	8.88
EPS Growth %	-	-8.03%	0.04%	-64.59%	221.74%
EPS (Basic)	8.47	7.79	7.79	2.77	8.94
Diluted Shares Outstanding	172.47M	172.47M	172.71M	173.7M	175.3M
Basic Shares Outstanding	172.47M	172.47M	172.71M	173.2M	174.1M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	2.19B	2.23B	2.52B	3.25B	3.86B
Cash & Short-Term Investments	91M	61M	194M	762M	878M
Cash Only	91M	61M	194M	762M	878M
Short-Term Investments	0	0	0	0	0
Accounts Receivable	1.18B	1.17B	1.31B	1.23B	1.03B
Days Sales Outstanding	52.58	52.57	58.47	54.35	45.33
Inventory	813M	873M	857M	965M	1.07B
Days Inventory Outstanding	91.36	92.76	89.27	96.21	100.44
Other Current Assets	108M	126M	155M	293M	881M
Total Non-Current Assets+	11.89B	11.36B	11.42B	11.21B	10.44B
Property, Plant & Equipment	1.31B	1.32B	1.46B	1.62B	1.33B
Fixed Asset Turnover	6.26x	6.16x	5.63x	5.09x	6.28x
Goodwill	6.67B	6.43B	6.54B	6.38B	5.7B
Intangible Assets	3.66B	3.25B	2.9B	2.54B	2.59B
Long-Term Investments	0	0	0	0	0
Other Non-Current Assets	253M	358M	530M	665M	813M
Total Assets+	14.07B	13.59B	13.94B	14.46B	14.29B
Asset Turnover	0.58x	0.60x	0.59x	0.57x	0.58x
Asset Growth %	-	-3.42%	2.57%	3.69%	-1.13%
Total Current Liabilities+	1.41B	1.31B	1.73B	2.7B	3.14B
Accounts Payable	320M	348M	477M	618M	687M
Days Payables Outstanding	35.96	36.98	49.69	61.61	64.73
Short-Term Debt	0	0	0	200M	0
Deferred Revenue (Current)	574M	559M	574M	572M	621M
Other Current Liabilities	323M	236M	365M	659M	2.52B
Current Ratio	1.56x	1.70x	1.46x	1.20x	1.23x
Quick Ratio	0.98x	1.04x	0.96x	0.84x	0.89x
Cash Conversion Cycle	107.98	108.36	98.05	88.94	81.04
Total Non-Current Liabilities+	610M	541M	549M	8.79B	6.11B
Long-Term Debt	0	0	8.3B	7.81B	5.04B
Capital Lease Obligations	0	0	0	0	0
Deferred Tax Liabilities	218M	215M	231M	225M	164M
Other Non-Current Liabilities	392M	326M	-7.99B	760M	910M
Total Liabilities	2.02B	1.85B	2.28B	11.5B	9.24B
Total Debt+	0	0	8.3B	8.01B	5.04B
Net Debt	-91M	-61M	8.11B	7.25B	4.16B
Debt / Equity	-	-	0.71x	2.71x	1.00x
Debt / EBITDA	-	-	3.69x	5.03x	2.31x
Net Debt / EBITDA	-0.04x	-0.03x	3.60x	4.56x	1.91x
Interest Coverage	-	-	-	2.82x	6.29x
Total Equity+	12.06B	11.74B	11.67B	2.96B	5.05B
Equity Growth %	-	-2.63%	-0.65%	-74.64%	70.63%
Book Value per Share	69.92	68.08	67.55	17.04	28.80
Total Shareholders' Equity	12.06B	11.74B	11.67B	2.96B	5.05B
Common Stock	0	0	0	2M	2M
Retained Earnings	0	0	0	242M	1.8B
Treasury Stock	0	0	0	0	0
Accumulated OCI	-200M	-497M	-337M	-1.06B	-625M
Minority Interest	0	0	0	0	0

Cash Flow

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	2.2B	1.68B	1.92B	1.19B	369M
Operating CF Margin %	26.95%	20.65%	23.36%	14.36%	4.43%
Operating CF Growth %	-	-23.75%	14.06%	-38.12%	-68.86%
Net Income	1.46B	1.34B	1.35B	479M	1.56B
Depreciation & Amortization	597M	578M	561M	555M	489M
Stock-Based Compensation	38M	37M	39M	112M	161M
Deferred Taxes	-34M	-141M	-142M	-155M	-120M
Other Non-Cash Items	74M	64M	-15M	34M	-1.72B
Working Capital Changes	67M	-202M	126M	160M	0
Change in Receivables	-1M	-32M	-129M	276M	34M
Change in Inventory	-136M	-82M	23M	-132M	-139M
Change in Payables	68M	25M	105M	266M	104M
Cash from Investing+	-278M	-253M	-230M	-380M	2.8B
Capital Expenditures	-277M	-251M	-290M	-380M	-379M
CapEx % of Revenue	3.39%	3.09%	3.54%	4.6%	4.55%
Acquisitions	0	0	60M	0	-696M
Investments	-	-	-	-	-
Other Investing	-1M	-2M	0	0	3.87B
Cash from Financing+	-1.96B	-1.46B	-1.55B	-240M	-3.06B
Debt Issued (Net)	0	0	0	8B	0
Equity Issued (Net)	0	0	0	0	0
Dividends Paid	0	0	0	0	0
Share Repurchases	0	0	0	0	0
Other Financing	-1.96B	-1.46B	-1.55B	-8.24B	-3.06B
Net Change in Cash	-33M	-30M	133M	568M	116M
Free Cash Flow+	1.93B	1.43B	1.63B	805M	-10M
FCF Margin %	23.56%	17.56%	19.82%	9.75%	-0.12%
FCF Growth %	-	-25.82%	13.8%	-50.46%	-101.24%
FCF per Share	11.16	8.28	9.41	4.63	-0.06
FCF Conversion (FCF/Net Income)	1.51x	1.25x	1.42x	2.47x	0.24x
Interest Paid	0	0	0	287M	0
Taxes Paid	0	0	0	244M	0

Key Ratios

Metric	2021	2022	2023	2024	2025
Return on Equity (ROE)	12.11%	11.29%	11.5%	6.55%	38.86%
Return on Invested Capital (ROIC)	11.78%	10.74%	8.07%	5.18%	16.85%
Gross Margin	60.25%	57.75%	57.25%	55.65%	53.47%
Net Margin	17.87%	16.52%	16.42%	5.8%	18.69%
Debt / Equity	-	-	0.71x	2.71x	1.00x
Interest Coverage	-	-	-	2.82x	6.29x
FCF Conversion	1.51x	1.25x	1.42x	2.47x	0.24x
Revenue Growth	-	-0.5%	0.82%	0.7%	0.86%

Solventum Corporation (SOLV) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare SOLV vs Peers

vs HCSG

vs AMN

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Solventum Corporation (SOLV) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare SOLV vs Peers

vs HCSG

vs AMN

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios